References
For reviews see:
<A NAME="RD02503ST-1A">1a</A>
Ottenheijm HCJ.
Herscheid JDM.
Chem.
Rev.
1986,
86:
697
<A NAME="RD02503ST-1B">1b</A>
Marraud M.
Vanderesse R. In
Houben-Weyl,
Methods of Organic Chemistry
4th ed., Vol. E22c:
Goodman M.
Thieme;
Stuttgart:
2002.
<A NAME="RD02503ST-2A">2a</A> Isolation
and structure determination:
Umezawa K.
Nakazawa K.
Ikeda Y.
Naganawa H.
Kondo S.
J.
Org. Chem.
1999,
64:
3034
<A NAME="RD02503ST-2B">2b</A> Biosynthesis of polyoxypeptin A:
Umezawa K.
Ikeda Y.
Kawase O.
Naganawa H.
Kondo S.
J. Chem. Soc., Perkin Trans.
1
2001,
1550
<A NAME="RD02503ST-3A">3a</A>
Garrouste P.
Pawlowski M.
Tonnaire T.
Sicsic S.
Dumy P.
de Rosny E.
Reboud-Ravaux M.
Fulcrand P.
Martinez J.
Eur. J. Med. Chem.
1998,
33:
423
<A NAME="RD02503ST-3B">3b</A>
Marastoni M.
Bazzaro M.
Salvadori S.
Bortolotti F.
Tomatis R.
Bioorg.
Med. Chem.
2001,
9:
939
<A NAME="RD02503ST-4A">4a</A>
Dupont V.
Lecoq A.
Mangeot J.-P.
Aubry A.
Boussard G.
Marraud M.
J. Am. Chem.
Soc.
1993,
115:
8898
<A NAME="RD02503ST-4B">4b</A>
Takeuchi Y.
Marshall GR.
J. Am. Chem. Soc.
1998,
120:
5363
Selected examples:
<A NAME="RD02503ST-5A">5a</A>
Akiyama M.
Katoh A.
Mutsui Y.
Watanabe Y.
Umemoto K.
Chem. Lett.
1996,
915
<A NAME="RD02503ST-5B">5b</A>
Hara Y.
Akiyama M.
J. Am. Chem. Soc.
2001,
123:
7247
<A NAME="RD02503ST-6">6</A>
Kolosa T.
Chimiak A.
Tetrahedron
1977,
33:
3285
Formation of the N-benzyloxy
amide link is very sensitive to steric hindrance and generally requires
strong acylating systems such as HATU {N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethan-aminium hexafluorophosphate} see:
<A NAME="RD02503ST-7A">7a</A>
Akiyama M.
Iesaki K.
Katoh A.
Shimizu K.
J. Chem. Soc., Perkin Trans. 1
1986,
851
<A NAME="RD02503ST-7B">7b</A>
Bianco A.
Zabel C.
Walden P.
Jung G.
J. Peptide Sci.
1998,
4:
471
<A NAME="RD02503ST-8A">8a</A> Nucleophilic
substitution on α-bromo acid:
Kolasa T.
Chimiak A.
Tetrahedron
1974,
30:
3591
<A NAME="RD02503ST-8B">8b</A> Use of α-hydroxy
acid via the triflate derivative:
Feenstra RW.
Stokkingreef EHM.
Nivard RJF.
Ottenheijm HCJ.
Tetrahedron
1988,
44:
5583
<A NAME="RD02503ST-8C">8c</A> Under Mitsunobu conditions:
Hanessian S.
Yang R.-Y.
Synlett
1995,
633
<A NAME="RD02503ST-8D">8d</A> Oxyamination of N-acylsultam enolate:
Oppolzer W.
Tamura O.
Deerberg J.
Helv. Chim. Acta
1992,
75:
1965
<A NAME="RD02503ST-8E">8e</A> Oxidation of α-amino
acid derivatives:
Grundke G.
Keese W.
Rimpler M.
Synthesis
1987,
1115
<A NAME="RD02503ST-8F">8f</A> See also:
Feenstra RW.
Stokkingreef EHM.
Reichwein AM.
Lousberg WBH.
Ottenheijm HCJ.
Tetrahedron
1990,
46:
1745
<A NAME="RD02503ST-8G">8g</A> See also:
Detomaso A.
Curci R.
Tetrahedron Lett.
2001,
42:
755
<A NAME="RD02503ST-9">9</A>
Ottenheijm HCJ.
de Man JHM.
Synthesis
1975,
163
<A NAME="RD02503ST-10">10</A>
The two oxime isomers are separated
by liquid chromatography. No difference in diastereoselectivity
was observed in their reduction so that they were used as a mixture.
<A NAME="RD02503ST-11">11</A>
Tijhuis MW.
Herscheid JDM.
Ottenheijm HCJ.
Synthesis
1980,
890
<A NAME="RD02503ST-12">12</A> Reduction of 2h with
sodium cyanoborohydride was also inefficient
<A NAME="RD02503ST-13">13</A>
All new compounds gave spectroscopic
and analytical data in agreement with the assigned structures. Selected
example: N-hydroxy dipeptide (S,S)-3b: [α]D
25 -3.8
(c 2.26, CHCl3). 1H
NMR (300 MHz, CDCl3): δ = 7.08
(d, 3
J = 9.6
Hz, 1 H, CONH), 5.46 (br, 2 H, NHOH), 4.61 (dd, 3
J = 9.6 and
4.8 Hz, H, CHα Val), 4.21 (m,
2 H, OCH
2CH3),
3.66 (q, 3
J = 7.1 Hz,
1 H, CHα Ala), 2.23 (m, 1 H,
CH-i-Pr),
1.29 (t, 3
J = 7.0 Hz,
3 H, OCH2CH
3),
1.26 (d, 3
J = 7.1
Hz, 3 H, CH
3 Ala), 0.97 (d, 3
J = 6.9 Hz,
3 H, CH
3-i-Pr),
0.91 (d, 3
J = 6.9
Hz, 3 H, CH
3-i-Pr). 13C
NMR (75.5 MHz, CDCl3): δ = 174.0, 172.8,
62.2, 61.6, 56.7, 31.2, 19.2, 17.7, 15.6, 14.3. MS (CI): m/z = 233
(100, M + H+), 187 (60), 159 (53).
IR (KBr,
cm-1): 3323 (m),
3254 (w), 2977 (m), 1738 (s), 1663 (s), 1541 (s).
<A NAME="RD02503ST-14">14</A>
Typical example: reduction of 9.33
mmol of 2b gave after flash chromatography
(silica gel; CH2Cl2-MeOH, 97:3) 3.82 mmol
of the first diastereomer, 0.53 mmol of a 1:1 mixture (estimated
from 1H NMR) and 3.69 mmol of the second diastereomer.
<A NAME="RD02503ST-15">15</A>
See ref. 1 and references therein.
<A NAME="RD02503ST-16">16</A>
Compound (S,S,S)-4 {Fmoc-Ala1Ψ[CO(NOH)]Ala2Val3-OEt}: [α]D
25 -12.7
(c 1.28, CHCl3). 1H
NMR (300 MHz, CDCl3): δ = 8.94
(s, 1 H, OH), 7.73 (d, 3
J = 7.4
Hz, 2 H, CHar Fmoc), 7.58 (d, 3
J = 7.4 Hz,
2 H, CHar Fmoc), 7.37 (dd, 3
J = 7.4 and
7.4Hz, 2 H, CHar Fmoc), 7.27 (dd, 3
J = 7.4 and
7.4 Hz, 1 H, CHar Fmoc), 7.27 (dd, 3
J = 7.4 and
7.4 Hz, 1 H, CHar Fmoc), 7.16 (br d, 3
J = 8.7 Hz,
1 H, NH Val3), 5.96 (d, 3
J = 7.0 Hz,
1 H, NH Ala1), 5.29 (q, 3
J = 7.0 Hz,
1 H, CHα Ala2), 4.97
(dq, 3
J = 7.0
and 6.8 Hz, 1 H, CHα Ala1), 4.50
(dd, 3
J = 8.7
and 4.9 Hz, 1 H, CHα Val3),
4.38-4.27 (m, 2 H, CHH and CH Fmoc), 4.23-4.16 (m, 1 H,
CHH Fmoc), 4.17 (q, 3
J = 7.1 Hz,
2 H, OCH
2CH3),
2.21-2.09 (m, 1 H, CH-i-Pr Val3),
1.49 (d, 3
J = 7.0
Hz, 3 H, CH
3 Ala2),
1.42 (d, 3
J = 6.8
Hz, 3 H, CH
3 Ala1),
1.23 (t, 3
J = 7.1
Hz, 3 H, OCH2CH
3),
0.91 (d, 3
J = 6.9
Hz, 3 H, CH
3-i-Pr
Val3), 0.88 (d, 3
J = 6.9
Hz, 3 H, CH
3-i-Pr
Val3). 13C NMR (50 MHz, CDCl3): δ = 172.8,
172.3, 171.7, 156.4, 143.9, 141.4, 127.8, 127.2, 125.3, 120.1, 67.4,
61.6, 57.3, 54.3, 47.2, 47.2, 31.5, 19.0, 18.2, 17.8, 14.5, 14.3.
MS (CI): m/z = 543
(27, M + NH4
+) 304 (100),
179 (69). IR (KBr, cm-1): 3316 (s br),
2964 (m), 1734 (s), 1701 (s), 1641 (s), 1533 (s), 1450 (s).
<A NAME="RD02503ST-17">17</A>
Selected 1H NMR
data (250 MHz, CDCl3) for compound 5: δ = 7.42
(br d, 3
J = 4.5
Hz, 1 H, -NH-O-CO-), 3.73 [qd, 3
J = 6.9 and
4.5 Hz, 1 H, -CH(CH3)-NH-O(CO)-].
<A NAME="RD02503ST-18">18</A>
Abbreviations: DCC, dicyclohexylcarbodiimide;
HOBt, 1-hydroxybenzotriazole; EDCI, 1-ethyl-3-(3′-dimethyl-aminopropyl)carbodiimide;
BOP, benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluoro-phosphate;
DMTMM, 4-(4, 6-dimethoxy[1,3,5]triazin-2-yl)-4-methyl-morpholinium
chloride.
<A NAME="RD02503ST-19A">19a</A> Preparation
of DMTMM:
Kunishima M.
Kawachi C.
Morita J.
Terao K.
Iwasaki F.
Tani S.
Tetrahedron
1999,
55:
13159
<A NAME="RD02503ST-19B">19b</A> Use in the synthesis of
hydroxamates:
De Luca L.
Giacomelli G.
Taddei M.
J. Org. Chem.
2001,
66:
2534
<A NAME="RD02503ST-20A">20a</A> Reaction
of N-alkyl hydroxylamine with mixed anhydrides
of amino acids:
Nakonieczna L.
Chimiak A.
Synthesis
1987,
418
<A NAME="RD02503ST-20B">20b</A> Acylation of optically
active N-hydroxy Leucine methyl ester
with simple acyl chlorides:
Jin Y.
Kim DH.
Tetrahedron: Asymmetry
1997,
8:
3699
<A NAME="RD02503ST-21">21</A>
Running the reaction in CDCl3 in
a NMR tube with 3 equiv of pyridine indicates that with 0.7 equiv
of TMSCl two exchanging products are first visible. After the addition
of an excess TMSCl (up to 2.2 equiv), only one product remains. This
is in agreement with previous findings (see ref. 20a).